L-Carnicure

Correction of Systemic Carnitine Deficiencies: Effectively restores plasma and tissue concentrations of levocarnitine in patients whose bodies cannot produce or retain adequate amounts due to genetic disorders or regular hemodialysis.

Optimization of Mitochondrial Fatty Acid Oxidation: Facilitates the transport of long-chain fatty acids into the cellular mitochondria, where they are oxidized to produce adenosine triphosphate (ATP), the primary energy currency of the cell.

Reduction of Dialysis-Related Complications: Clinical administration helps alleviate debilitating symptoms frequently experienced by chronic hemodialysis patients, including severe muscle cramping, persistent fatigue, and acute hypotension (low blood pressure).

Cardioprotective and Muscular Support: Supports optimal myocardial (heart muscle) and skeletal muscle metabolism by preventing the toxic accumulation of acyl-CoA esters, thereby improving functional tissue capacity and exercise tolerance.

Immediate Systemic Availability: The sterile aqueous injectable presentation bypasses gastrointestinal absorption limits, ensuring 100% bioavailability for immediate therapeutic utility in acute or severe deficiency states.